| Members |
targetComponentId |
| mannitol 10 %, infusionsvätska, lösning, flaska |
Product containing only mannitol in parenteral dose form (medicinal product form) |
| Mannitol 10g/100mL injection |
Mannitol 100 mg/mL solution for injection |
| mannitol 10 g/100 ml, injektionsvätska, lösning, påse 1 000 ml |
Mannitol 100 mg/mL solution for injection |
| mannitol 10 g/100 ml, injektionsvätska, lösning, påse 500 ml |
Mannitol 100 mg/mL solution for injection |
| mannitol 20 %, infusionsvätska, lösning, påse 250 ml |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| mannitol 20 %, infusionsvätska, lösning, påse 500 ml |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| mannitol 20 %, infusionsvätska, lösning, flaska |
Product containing only mannitol in parenteral dose form (medicinal product form) |
| Manual insertion |
Insertion - action (qualifier value) |
| Marburg virus |
Genus Marburgvirus (organism) |
| Marburg virus disease |
Marburg virus disease |
| Marginal zone lymphoma |
Marginal zone B-cell lymphoma |
| marint kräftdjur, livsmedel |
Marine crustacean (substance) |
| marint blötdjur, livsmedel |
Marine mollusk (substance) |
| Marital maladjustment |
Maladjustment to married life |
| marlexpatch |
Polypropylene mesh (physical object) |
| maskulinitet hos flicka |
Gender identity finding |
| frakturtyper enligt Mason |
Fracture configurations |
| frakturtyp 1 enligt Mason |
Mason type I fracture (morphologic abnormality) |
| frakturtyp 2 enligt Mason |
Mason type II fracture |
| frakturtyp 3 enligt Mason |
Mason type III fracture (morphologic abnormality) |
| massör |
Massage therapist (occupation) |
| Masseur |
Massage therapist (occupation) |
| Mast cell leukemia |
Mast cell leukemia |
| maternell 15q11q13-deletion |
Angelman syndrome due to maternal monosomy 15q11q13 (disorder) |
| Maternal drug abuse |
Drug misuse by mother |
| maxatasspecifikt extrakt |
Product containing maxatase (medicinal product) |
| McCune-Albright syndrome |
Polyostotic fibrous dysplasia of bone |
| Measles with other specified complications |
Measles with complication |
| antikroppsanalys avseende Babesia equi |
Measurement of Theileria equi antibody (procedure) |
| analys med direkt fluorescens avseende antikropp mot Bacillus anthracis |
Measurement of Bacillus anthracis antigen using direct fluorescence (procedure) |
| antikroppsanalys med direkt fluorescens |
Direct tissue immunofluorescence procedure |
| mekanisk komplikation av bröstprotes |
Mechanical complication of breast prosthesis |
| mekanisk komplikation av cystostomikateter |
Mechanical complication of cystostomy catheter |
| mekanisk komplikation av hjärtklaffprotes |
Mechanical complication of heart valve prosthesis |
| mekanisk komplikation av intrauterint preventivmedel |
Mechanical complication of intrauterine contraceptive device |
| mekanisk komplikation av intraokulärt linsimplantat |
Mechanical complication of intraocular lens |
| Mechanical complication due to other implant or internal device, NOS |
Complication of surgical procedure |
| mekanisk komplikation orsakad av protesrekonstruktion av sädesledare |
Mechanical complication of prosthetic reconstruction of vas deferens |
| Mechanical complication of other specified device, implant or graft |
Complication of surgical procedure |
| Mechanical complication of other vascular device, implant or graft |
Mechanical complication of cardiac device, implant AND/OR graft |
| Mechanical strabismus from other musculofascial disorder |
Mechanical strabismus due to musculofascial disorder |
| meklozin 12,5 mg, pastill |
Product containing precisely meclozine hydrochloride 12.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
| biverkning av meklozinhydroklorid |
Adverse reaction to meclozine (disorder) |
| MedDRA - SNOMED CT simple map reference set |
MedDRA to SNOMED CT simple map reference set (foundation metadata concept) |
| Medial canthal ligament |
Structure of medial palpebral ligament |
| Medical cardiovascular procedure |
Procedure on cardiovascular system |
| Medical dermatologic procedure |
Procedure on integumentary system |
| Medical procedure on heart |
Procedure on heart |
| höjd läkemedelsdosering avböjd |
Medication dosage increase declined |
| Medicinal gas |
Gaseous dose form |
| medicinskt jod |
Iodine |
| läkemedel med behandlingsfunktion mot gikt |
Uricosuric agent |
| läkemedel med behandlingsfunktion som motgift |
Product containing antivenom (product) |
| Medicinal product containing mercury and/or mercury compound and acting as diuretic agent (product) |
Mercurial diuretic agent |
| Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
| medroxiprogesteronacetat 104 mg, injektionsvätska, suspension, förfylld spruta 0,65 ml |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
| Medullary carcinoma with amyloid stroma |
Medullary carcinoma with amyloid stroma |
| medulloblastom |
Medulloblastoma |
| Mefloquine hydrochloride 250mg tablet |
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Megakaryoblast |
Megakaryoblast |
| Megakaryocyte |
Megakaryocyte |
| Megarectum |
Megacolon, not Hirschsprung's |
| Meglumin iotroxinate |
Product containing iotroxic acid (medicinal product) |
| megluminjotalamat 60 %, infusionsvätska, lösning, flaska |
Iothalamate only product |
| melanocytnevus, kategori |
Pigmented nevus |
| melanoma in situ, indelning efter lokalisation |
Melanoma in situ |
| vaccin mot melanom |
Vaccine product |
| melanomvaccin |
Vaccine product |
| Melanoma: [skin] or [malignant] |
Malignant melanoma |
| Melanoma: [skin] or [malignant] |
Malignant melanoma |
| melanotisk neuroektodermal tumör hos barn |
Melanotic neuroectodermal tumor of infancy |
| Melasian type |
Melasian type |
| memantin 2 mg/ml, oral lösning |
Memantine hydrochloride 2 mg/mL oral solution |
| Membrane metallo-endopeptidase |
Lymphocyte antigen CD10 |
| Memory disturbance (& amnesia (& symptom)) |
Memory impairment (finding) |
| Memory impairment |
Memory impairment (finding) |
| meningeal tumör, oklart om benign eller malign |
Meningioma of uncertain behavior (morphologic abnormality) |
| meningiom |
Benign meningioma |
| biverkning av vaccin med meningokockpolysackarid |
Adverse reaction to meningococcal vaccine |
| Menstrual molimen |
Premenstrual tension syndrome |
| psykisk funktionsnedsättning |
Intellectual disability |
| Mental handicap (specialty) |
Intellectual disability specialty |
| psykisk funktionsnedsättning |
Intellectual disability specialty |
| Mental handicap (specialty) |
Intellectual disability specialty |
| avdelning för personer med psykisk funktionsnedsättning |
Intellectual disability psychiatry department (environment) |
| psykiatrisk vård för personer med psykisk funktionsnedsättning |
Intellectual disability psychiatry service |
| årlig fysisk undersökning av psykisk hälsa utförd |
Annual physical examination for people with mental illness completed |
| vårdplan för krisreaktion |
Mental health crisis plan |
| personlig hälsoplan för psykisk hälsa |
Mental health personal health plan |
| mental retardation |
Intellectual disability |
| screening för mental retardation |
Intellectual disability screening |
| mentol 35,55 mg, inhalationskapsel |
Product containing only menthol in pulmonary dose form (medicinal product form) |
| Mepacrine hydrochloride 100mg tablet |
Mepacrine hydrochloride 100 mg oral tablet |
| petidinhydroklorid 100 mg/ml, injektionsvätska, lösning, ampull |
Product containing only pethidine in parenteral dose form (medicinal product form) |
| petidinhydroklorid 50 mg/5 ml, sirap |
Pethidine hydrochloride 10 mg/mL oral solution |
| petidinhydroklorid 50 mg/ml, injektionsvätska, lösning, ampull |
Product containing only pethidine in parenteral dose form (medicinal product form) |
| petidinhydroklorid 50 mg + prometazinhydroklorid 50 mg, injektionsvätska, lösning, flaska |
Product containing only pethidine and promethazine (medicinal product) |
| mepivakainhydroklorid 3 % + levonordefrin 1:20 000, injektionsvätska, lösning, flaska |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
| mepivakainhydroklorid 30 mg + natriumklorid 3 mg, injektionsvätska, lösning, flaska |
Mepivacaine only product |
| mepivakainhydroklorid 2 % + adrenalin 1:100 000, cylinderampull |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
| Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |